PURPOSE: Clear cell renal cell carcinoma (ccRCC) is the most common primary malignant urologic tumor. The Fuhrman grading system is an independent indicator for aggressiveness and prognosis of ccRCC. We aimed to assess the possible diagnostic role of biexponentially and monoexponentially fitted signal attenuation for the Fuhrman grading. METHODS: A total of 33 patients with ccRCC underwent multiple b values (0, 20, 50, 100, 150, 250, 400, 600, 800, 1000 s/mm2) diffusion-weighted imaging (DWI). Biexponential parameters (fast ADC [ADCf], slow ADC [ADCs], and fraction of ADCf [f]) and monoexponential apparent diffusion coefficient were calculated, and correlated with the Fuhrman grade of ccRCC respectively. The performance of biexponential parameters in differentiating Fuhrman low- and high-grade tumors was assessed and compared with ADC value by receiver operating characteristic analysis. RESULTS: Qualified images and diffusion-weighted parameters were obtained for all patients. The ADCf and f value were positively correlated, whereas ADCs and ADC value were negatively correlated with Fuhrman grade. Significant differences were observed in ADCf (P < 0.001), ADCs (P = 0.005), and f values (P < 0.001) of high- and low-grade ccRCCs. When differentiating Fuhrman low-grade tumors from high-grade, the ADCf revealed an area under receiver operating characteristic curve of 0.959, which was higher than the ADC value (0.789; P = 0.046), while ADCs (0.807) and f (0.833) showed no significant difference from ADC (P = 0.85 for ADCs, P = 0.73 for f). CONCLUSION: Biexponential DWI provides additional parameters for ccRCC. ADCf is more accurate compared with the ADC value in characterizing Fuhrman grade of ccRCC.
PURPOSE:Clear cell renal cell carcinoma (ccRCC) is the most common primary malignant urologic tumor. The Fuhrman grading system is an independent indicator for aggressiveness and prognosis of ccRCC. We aimed to assess the possible diagnostic role of biexponentially and monoexponentially fitted signal attenuation for the Fuhrman grading. METHODS: A total of 33 patients with ccRCC underwent multiple b values (0, 20, 50, 100, 150, 250, 400, 600, 800, 1000 s/mm2) diffusion-weighted imaging (DWI). Biexponential parameters (fast ADC [ADCf], slow ADC [ADCs], and fraction of ADCf [f]) and monoexponential apparent diffusion coefficient were calculated, and correlated with the Fuhrman grade of ccRCC respectively. The performance of biexponential parameters in differentiating Fuhrman low- and high-grade tumors was assessed and compared with ADC value by receiver operating characteristic analysis. RESULTS: Qualified images and diffusion-weighted parameters were obtained for all patients. The ADCf and f value were positively correlated, whereas ADCs and ADC value were negatively correlated with Fuhrman grade. Significant differences were observed in ADCf (P < 0.001), ADCs (P = 0.005), and f values (P < 0.001) of high- and low-grade ccRCCs. When differentiating Fuhrman low-grade tumors from high-grade, the ADCf revealed an area under receiver operating characteristic curve of 0.959, which was higher than the ADC value (0.789; P = 0.046), while ADCs (0.807) and f (0.833) showed no significant difference from ADC (P = 0.85 for ADCs, P = 0.73 for f). CONCLUSION: Biexponential DWI provides additional parameters for ccRCC. ADCf is more accurate compared with the ADC value in characterizing Fuhrman grade of ccRCC.
Authors: Bernard Escudier; Tim Eisen; Walter M Stadler; Cezary Szczylik; Stéphane Oudard; Michael Siebels; Sylvie Negrier; Christine Chevreau; Ewa Solska; Apurva A Desai; Frédéric Rolland; Tomasz Demkow; Thomas E Hutson; Martin Gore; Scott Freeman; Brian Schwartz; Minghua Shan; Ronit Simantov; Ronald M Bukowski Journal: N Engl J Med Date: 2007-01-11 Impact factor: 91.245
Authors: S Rheinheimer; B Stieltjes; F Schneider; D Simon; S Pahernik; H U Kauczor; P Hallscheidt Journal: Eur J Radiol Date: 2011-11-21 Impact factor: 3.528
Authors: Hersh Chandarana; Stella K Kang; Samson Wong; Henry Rusinek; Jeff L Zhang; Shigeki Arizono; William C Huang; Jonathan Melamed; James S Babb; Edgar F Suan; Vivian S Lee; Eric E Sigmund Journal: Invest Radiol Date: 2012-12 Impact factor: 6.016
Authors: Suresh de Silva; Kathleen Rebecca Lockhart; Peter Aslan; Peter Nash; Anthony Hutton; David Malouf; Dominic Lee; Paul Cozzi; Fiona MacLean; James Thompson Journal: BMC Urol Date: 2021-04-22 Impact factor: 2.264